Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sentinel lymph node--why study it: implications of the B-32 study.

S P Harlow1, D N Krag

  • 1Department of Surgery, University of Vermont College of Medicine, Burlington, VT 05405-0068, USA.

Seminars in Surgical Oncology
|August 28, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiple antibodies targeting tumor-specific mutations redirect immune cells to inhibit tumor growth and increase survival in experimental animal models.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2019
Same author

Intrusive thoughts and avoidance in breast cancer: Individual differences and association with psychological distress.

Psychology & health·2011
Same author

Sentinel lymph node biopsy for breast cancer.

Journal of surgical oncology·2007
Same author

Calorimetric investigation of phosphorylated and non-phosphorylated peptide ligand binding to the human Grb7-SH2 domain.

Journal of molecular recognition : JMR·2007
Same author

Combination treatment with Grb7 peptide and Doxorubicin or Trastuzumab (Herceptin) results in cooperative cell growth inhibition in breast cancer cells.

British journal of cancer·2007
Same author

Sentinel lymph node biopsy in breast cancer.

Breast disease·2005

Sentinel lymph node (SLN) biopsy offers accurate staging for breast cancer patients. This clinical trial compares SLN biopsy alone versus with axillary dissection to evaluate safety and effectiveness.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Clinical Trials

Background:

  • Axillary lymph node dissection is the standard for breast cancer staging and regional control but causes significant morbidity.
  • Sentinel lymph node (SLN) biopsy provides accurate staging but its impact on long-term outcomes is unknown.

Purpose of the Study:

  • To compare the safety and efficacy of SLN biopsy alone versus SLN biopsy with completion axillary node dissection.
  • To evaluate the impact of SLN biopsy on regional disease control and patient survival in breast cancer management.

Main Methods:

  • Phase III prospective, randomized clinical trial (B-32 trial) sponsored by the National Cancer Institute (NCI).
  • Comparison of treatment arms: SLN biopsy alone vs. SLN biopsy plus completion axillary node dissection.

Related Experiment Videos

  • Patient population: Clinically node-negative breast cancer patients.

    • Main Results:

    • The trial aims to provide evidence regarding the safety of SLN biopsy procedures.
    • Results will determine if SLN biopsy alone is non-inferior to axillary dissection for regional disease control and survival.

    Conclusions:

    • SLN biopsy is a less invasive staging procedure for breast cancer.
    • The B-32 trial will establish the role of SLN biopsy in breast cancer management and patient outcomes.